Abstract
Lymphomas with subtle patterns in the marrow can be a diagnostic challenge, unless a high index of suspicion is maintained. We present two patients with aggressive lymphomas who presented with cytopenias and the subsequent bone marrow examinations yielded surprising results. These cases highlight the potential usefulness of a bone marrow examination in the diagnosis of lymphomas in the absence of nodal or other tissue specimens.
References
Foucar K, Reichard K, Czuchlewski D (2010) Bone marrow pathology, 3rd edn. ASCP Press, Chicago
Swerdlow SH, International Agency for Research on Cancer., World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours, 4th edn. International Agency for Research on Cancer, Lyon
Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renz AO, Doglioni C, Montalban C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Dalla Libera A, Pertoldi B, Horvath B, Szomor A, Zucca E, Cavalli F, Ponzoni M (2007) Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica 92(4):486–492
Morice WG, Rodriguez FJ, Hoyer JD, Kurtin PJ (2005) Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Mod Pathol 18(4):495–502. doi:10.1038/modpathol.3800297
Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, Hsi ED (2001) Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol 14(11):1147–1156. doi:10.1038/modpathol.3880450
Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, Paolino S, Cassisa A, Patriarca C (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31(2):220–226
Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, Niitsu N, Kosugi H, Tsukamoto N, Miwa H, Asaoku H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T (2008) Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26(19):3189–3195. doi:10.1200/JCO.2007.15.4278
Bazhenova L, Higginbottom P, Mason J (2006) Intravascular lymphoma: a role for single-agent rituximab. Leuk Lymphoma 47(2):337–341. doi:10.1080/10428190500300837
Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F, Nakamura S (2007) Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25(21):3168–3173. doi:10.1200/JCO.2006.08.2313
Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF, Divine M, Haioun C, Zafrani S, Goossens M et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75(11):2213–2219
Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124–4130. doi:10.1200/JCO.2008.16.4558
Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M (2007) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44(2):265–267. doi:10.1097/MPG.0b013e31802f6424
Chen YH, Chadburn A, Evens AM, Winter JN, Gordon LI, Chenn A, Goolsby C, Peterson L (2011) Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-gammadelta T-cell large granular lymphocytic leukemia. Am J Clin Pathol 136(2):289–299. doi:10.1309/AJCPTFFQ18JMYKDF
Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri SA (2009) Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 6(12):707–717. doi:10.1038/nrclinonc.2009.169
Foppoli M, Ferreri AJ (2014) Gamma-delta t-cell lymphomas. Eur J Haematol. doi:10.1111/ejh.12439
Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102(13):4261–4269. doi:10.1182/blood-2003-05-1675
Nosari A, Oreste PL, Biondi A, Costantini MC, Santoleri L, Intropido L, Muti G, Pungolino E, Gargantini L, Morra E (1999) Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome. Am J Hematol 60(1):61–65. doi:10.1002/(SICI)1096-8652(199901)60:1<61:AID-AJH10>3.0.CO;2-L
Gaulard P, Belhadj K, Reyes F (2003) Gammadelta T-cell lymphomas. Semin Hematol 40(3):233–243 (S0037196303001379)
Schafer E, Chen A, Arceci RJ (2009) Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant. Pediatr Blood Cancer 53(6):1127–1129. doi:10.1002/pbc.22129
Weidmann E (2000) Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 14(6):991–997
Mittal S, Milner BJ, Johnston PW, Culligan DJ (2006) A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur J Haematol 76(6):531–534. doi:10.1111/j.1600-0609.2006.00646.x
Jaeger G, Bauer F, Brezinschek R, Beham-Schmid C, Mannhalter C, Neumeister P (2008) Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. Ann Oncol 19(5):1025–1026. doi:10.1093/annonc/mdn119mdn119
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhat, R., Pai, S., Das, K. et al. Aggressive Lymphomas Diagnosed in the Bone Marrow: Two Illustrative Cases. Indian J Hematol Blood Transfus 32 (Suppl 1), 125–129 (2016). https://doi.org/10.1007/s12288-015-0520-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0520-7